Josien Haan

503 total citations
22 papers, 352 citations indexed

About

Josien Haan is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Josien Haan has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Josien Haan's work include Genetic factors in colorectal cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Josien Haan is often cited by papers focused on Genetic factors in colorectal cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Josien Haan collaborates with scholars based in Netherlands, United States and United Kingdom. Josien Haan's co-authors include Bauke Ylstra, Gerrit A. Meijer, Heike I. Grabsch, Philip Quirke, Beatriz Carvalho, Tineke E. Buffart, Alexander Engel, Rebecca P. M. Brosens, Miguel A. Cuesta and Irıs D. Nagtegaal and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Josien Haan

20 papers receiving 348 citations

Peers

Countries citing papers authored by Josien Haan

Since Specialization

Citations

This map shows the geographic impact of Josien Haan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josien Haan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josien Haan more than expected).

Fields of papers citing papers by Josien Haan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josien Haan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josien Haan. The network helps show where Josien Haan may publish in the future.

Co-authorship network of co-authors of Josien Haan

This figure shows the co-authorship network connecting the top 25 collaborators of Josien Haan. A scholar is included among the top collaborators of Josien Haan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josien Haan. Josien Haan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer. 2024 ·Journal of Clinical Oncology ·Erin F. Cobain, Lajos Pusztai, Cathy Graham, Pat W. Whitworth, Peter D. Beitsch, Cynthia R. Osborne, Rakhshanda Layeequr Rahman, Nathalie Johnson, Adam Brufsky, Reshma Mahtani, (unknown), Kent Hoskins, Hannah M. Linden, Rita A. Mukhtar, Laura J. Esserman, Josien Haan, Katie Quinn, Andrea Menicucci, M. William Audeh, Joyce O’Shaughnessy, (unknown)	3
2	BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance 2022 ·Breast Cancer Research and Treatment ·(unknown), (unknown), (unknown), Josien Haan, Rajith Bhaskaran, Diederik Wehkamp, Andrea Menicucci, (unknown), Lorenza Mittempergher, Annuska M. Glas	6
3	Identification of transcriptional changes with MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant chemotherapy. 2022 ·Journal of Clinical Oncology ·Alice Chung, Marissa K. Srour, Farnaz Dadmanesh, Sungjin Kim, Armando E. Giuliano, Jennifer Wei, (unknown), Josien Haan, Shiyu Wang, Andrea Menicucci, Patricia Dauer, M. William Audeh	1
4	Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature. 2021 ·Journal of Clinical Oncology ·Joyce O’Shaughnessy, Virginia Kaklamani, Yuan Yuan, (unknown), Sami Diab, Jennifer A. Crozier, Pat W. Whitworth, Karen L. Tedesco, (unknown), Rakhshanda Layeequr Rahman, Carlos A. Encarnacion, Josien Haan, (unknown), Andrea Menicucci, William Audeh, (unknown)	0
5	MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients 2021 ·Genes Chromosomes and Cancer ·Josien Haan, Rajith Bhaskaran, (unknown), (unknown), (unknown), (unknown), (unknown), Frédérique Penault‐Llorca, Lorenza Mittempergher, Annuska M. Glas	19
6	220P Annotating MammaPrint and BluePrint gene profile to the Hallmarks of cancer and understanding the biology of MammaPrint extreme risk groups 2020 ·Annals of Oncology ·Josien Haan, Rajith Bhaskaran, Lorenza Mittempergher, (unknown), William Audeh, Frédérique Penault‐Llorca, Annuska M. Glas	1
7	Small chromosomal regions position themselves autonomously according to their chromatin class 2017 ·Genome Research ·Harmen J.G. van de Werken, Josien Haan, Yana Feodorova, Dominika Bijos, (unknown), Koen Theunis, Sjoerd J.B. Holwerda, Wouter Meuleman, Ludo Pagie, Katharina Thanisch, Parveen Kumar, Heinrich Leonhardt, Peter Marynen, Bas van Steensel, Thierry Voet, Wouter de Laat, Irina Solovei, Boris Joffe	27
8	High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer 2015 ·PLoS ONE ·Evert van den Broek, (unknown), Oscar Krijgsman, Daoud Sie, Josien Haan, Joleen J.H. Traets, Mark A. van de Wiel, Irıs D. Nagtegaal, Cornelis J.A. Punt, Beatriz Carvalho, Bauke Ylstra, Sanne Abeln, Gerrit A. Meijer, Remond J.A. Fijneman	19
9	Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent 2014 ·PLoS ONE ·Leonie J. Mekenkamp, Josien Haan, (unknown), (unknown), Jeroen R. Dijkstra, (unknown), Cornelis J.A. Punt, Gerrit A. Meijer, Irıs D. Nagtegaal, Bauke Ylstra	18
10	Genomic landscape of metastatic colorectal cancer 2014 ·Nature Communications ·Josien Haan, Mariëtte Labots, Christian Rausch, Miriam Koopman, Jolien Tol, Leonie J. Mekenkamp, Mark A. van de Wiel, (unknown), Hendrik F. van Essen, Nicole C.T. van Grieken, Quirinus J.M. Voorham, Linda J.W. Bosch, Xueping Qu, Omar Kabbarah, Henk M.W. Verheul, Irıs D. Nagtegaal, Cornelis J.A. Punt, Bauke Ylstra, Gerrit A. Meijer	45
11	Abstract 1155: Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in colorectal cancer. 2013 ·Cancer Research ·Linda J.W. Bosch, Geert Trooskens, Pétur Snæbjörnsson, Josien Haan, Lorraine Pelosof, Miriam Koopman, Jolien Tol, Joost Louwagie, Luc Dehaspe, Bauke Ylstra, Henk M.W. Verheul, Manon van Engeland, Irıs D. Nagtegaal, James G. Herman, Cornelis J.A. Punt, Wim Van Criekinge, Beatriz Carvalho, Gerrit A. Meijer	1
12	High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection 2013 ·Cellular Oncology ·Mariëtte Labots, Tineke E. Buffart, Josien Haan, Nicole C.T. van Grieken, Marianne Tijssen, Cornelis J.�H. van de Velde, Heike I. Grabsch, Bauke Ylstra, Beatriz Carvalho, Remond J.A. Fijneman, Henk M.W. Verheul, Gerrit A. Meijer	13
13	Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer 2012 ·Gut ·Leonie J. Mekenkamp, Josien Haan, Miriam Koopman, M. Elisa Vink-Börger, (unknown), Steven Teerenstra, Bauke Ylstra, Gerrit A. Meijer, Cornelis J.A. Punt, Irıs D. Nagtegaal	16
14	CGH arrays compared for DNA isolated from formalin‐fixed, paraffin‐embedded material 2011 ·Genes Chromosomes and Cancer ·Oscar Krijgsman, (unknown), Josien Haan, Hendrik F. van Essen, Serge Smeets, Paul P. Eijk, Renske D.M. Steenbergen, Klaas Kok, Sabine Tejpar, Gerrit A. Meijer, Bauke Ylstra	31
15	Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers 2011 ·Annals of Oncology ·Josien Haan, Tineke E. Buffart, Paul P. Eijk, Mark A. van de Wiel, Wessel N. van Wieringen, P D Howdle, Chris J. Mulder, Cornelis JH van de Velde, Philip Quirke, Irıs D. Nagtegaal, Nicole C.T. van Grieken, Heike I. Grabsch, Gerrit A. Meijer, Bauke Ylstra	32
16	Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients 2011 ·Pure Amsterdam UMC ·Rebecca P. M. Brosens, Eric J.T. Belt, Josien Haan, Tineke E. Buffart, Beatriz Carvalho, Heike I. Grabsch, Philip Quirke, Miguel A. Cuesta, Alexander Engel, Bauke Ylstra, Gerrit A. Meijer	27
17	Candidate driver genes in focal chromosomal aberrations of stage II colon cancer 2010 ·The Journal of Pathology ·Rebecca P. M. Brosens, Josien Haan, Beatriz Carvalho, François Rustenburg, Heike I. Grabsch, Philip Quirke, Alexander Engel, Miguel A. Cuesta, Nicola Maughan, Marcel J. Flens, Gerrit A. Meijer, Bauke Ylstra	40
18	Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients 2010 ·Analytical Cellular Pathology ·Rebecca P. M. Brosens, Eric J.T. Belt, Josien Haan, Tineke E. Buffart, Beatriz Carvalho, Heike I. Grabsch, Philip Quirke, (unknown), Alexander Engel, Bauke Ylstra, Gerrit A. Meijer	9
19	Deletion of chromosome 4q predicts outcome in stage II colon cancer patients. 2010 ·SHILAP Revista de lepidopterología ·Rebecca P. M. Brosens, Eric J.T. Belt, Josien Haan, Tineke E. Buffart, Beatriz Carvalho, Heike I. Grabsch, Philip Quirke, Miguel A. Cuesta, Alexander Engel, Bauke Ylstra, Gerrit A. Meijer	33
20	Automatic discovery of cross-family sequence features associated with protein function 2006 ·BMC Bioinformatics ·Markus Brameier, Josien Haan, (unknown), Robert M. MacCallum	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact